{"title":"Methotrexate-LoadednSurface-Modified Solid Lipid NanoparticlesnTargeting Cancer Expressing COX‑2 Enzyme","authors":"Swagata Patra (16494751), Joykrishna Dey (1521112), Somnath Kar (18499890), Avik Chakraborty (611224), Megha Tawate (18996342)","doi":"10.1021/acs.langmuir.4c00638.s001","DOIUrl":"https://doi.org/10.1021/acs.langmuir.4c00638.s001","url":null,"abstract":"Cancer is a major public health problem worldwide, andnit is thensecond leading cause of death of humans in the world. The presentnstudy has been directed toward the preparation of methotrexate-loadednsurface-modified solid lipid nanoparticles (SLNs) for potential usenas a chemotherapeutic formulation for cancer therapy. A lipid (C<sub>14</sub>-AAP) derived from myristic acid (C<sub>14</sub>H<sub>30</sub>O<sub>2</sub>) and acetaminophen (AAP) was employed as a targetingnligand for human breast and lung cancer cells that overexpress thencyclooxygenases-2 (COX-2) enzyme. The SLNs consisting of stearic acidnand C<sub>14</sub>-AAP were characterized by several methods, includingndynamic light scattering (DLS), differential scanning calorimetryn(DSC), powder X-ray diffraction (PXRD), ultraviolet–visiblen(UV–vis) spectroscopy, high-resolution transmission electronnmicroscopy (HRTEM), and field emission scanning electron microscopyn(FESEM) techniques. An in vitro cell cytotoxicity study was done byncarrying out an MTT assay and flow cytometry study in the human breastncancer (MCF7) and human lung cancer cell line (A549). The expressionnlevel of COX-2 enzyme in MCF7 and A549 cell lines was examined bynreverse transcription polymerase chain reaction (RT-PCR). A high levelnof COX-2 expression was observed in both cell lines. In vitro cellncytotoxicity study in MC7 and A549 cell lines showed the surface-modified,nmethotrexate-loaded SLN is more effective in cell killing and inductionnof apoptotic death in both the cell lines than free methotrexate innMTT, flow cytometry, clonogenic assay, and Western blot studies. Thensurface-modified SLN was radiolabeled with <sup>99m</sup>Tc with %RCPngreater than 95%. In vivo biodistribution study of the <sup>99m</sup>Tc-labeled SLN in melanoma tumor-bearing C57BL6 mice showed moderatentumor uptake of the radiotracer at 3 h post injection. The SPECT/CTnimage aligns with the biodistribution results. This study shows thatnAAP-modified SLNs could be a potential chemotherapeutic formulationnfor cancer therapy.","PeriodicalId":522371,"journal":{"name":"Figshare","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://figshare.com/articles/journal_contribution/Methotrexate-Loaded_Surface-Modified_Solid_Lipid_Nanoparticles_Targeting_Cancer_Expressing_COX_2_Enzyme/26213367","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147896004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}